Table 1 Patient characteristics

From: Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

Characteristic

No.

(%)

Total

46

(100)

Age – median (range)

61 (35–79)

 

Country

 France

21

(46)

 USA

25

(54)

Performance status

 ECOG 0

30

(65)

 ECOG 1

15

(33)

 ECOG 2

1

(2)

Sex

 Male

22

(48)

 Female

24

(52)

Ethnicity

 Caucasian

43

(93)

 African-American

3

(7)

Tumour size

3.0 cm

27

(64)

 <3.0 cm

15

(36)

 Unknown

4

(—)

Lymph node

 Negative

13

(30)

 Positive

30

(70)

 Unknown

3

(—)

Tumour stage

 T1/T2

12

(27)

 T3/T4

32

(73)

 Unknown

2

(−)